Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,718 | -28,008 | -108,176 | -79,116 | -50,066 |
| Depreciation Amortization | -584 | -312 | 1,608 | 819 | 630 |
| Accounts receivable | 2,000 | 2,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 340 | 1,552 | 1,097 | 2,137 | -2,356 |
| Other Working Capital | -21,199 | -11,687 | -18,493 | -14,515 | -19,138 |
| Other Operating Activity | 8,781 | 1,548 | 14,884 | 9,861 | 9,727 |
| Operating Cash Flow | $-59,380 | $-34,907 | $-109,080 | $-80,814 | $-61,203 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,284 | -620 | -7,692 | -6,651 | -3,372 |
| Purchase Of Investment | -103,311 | -52,534 | -208,504 | -114,947 | -70,492 |
| Sale Of Investment | 168,833 | 84,705 | 242,595 | 160,602 | 97,640 |
| Investing Cash Flow | $64,238 | $31,551 | $26,399 | $39,004 | $23,776 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 659 | 73 | 1,623 | 1,096 | 983 |
| Other Financing Activity | 0 | 0 | -8 | -8 | -8 |
| Financing Cash Flow | $659 | $73 | $1,615 | $1,088 | $975 |
| Beginning Cash Position | 63,958 | 63,958 | 145,024 | 145,024 | 145,024 |
| End Cash Position | 69,475 | 60,675 | 63,958 | 104,302 | 108,572 |
| Net Cash Flow | $5,517 | $-3,283 | $-81,066 | $-40,722 | $-36,452 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,380 | -34,907 | -109,080 | -80,814 | -61,203 |
| Capital Expenditure | -1,284 | -620 | -7,692 | -6,651 | -3,372 |
| Free Cash Flow | -60,664 | -35,527 | -116,772 | -87,465 | -64,575 |